Merck Sharp & Dohme Corp. vs. Genentech, Inc. et al.
Explore the PTAB proceeding IPR2016-01373 filed by Merck Sharp & Dohme Corp. on 2016-07-07. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2016-01373
Filing Date
2016-07-07
Accorded Filing Date
2016-07-07
Institution Decision Date
2017-01-03
Last Modified Date
β
Proceeding Type
IPR
Termination Date
β
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Merck Sharp & Dohme Corp.
Represented By
Nimrod, Raymondet alPatent Owner / Respondent
Genentech, Inc. et al.
Represented By
Cavanaugh, Davidet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Merck Sharp & Dohme Corp. v. Genentech, Inc. et al.
Mylan Pharmaceuticals Inc. et al. v. Genentech, Inc. et al.
Genzyme Corporation et al. v. GENENTECH, INC. et al.
GENZYME CORPORATION et al. v. Genentech Inc. et al.
Sanofi-Aventis U.S. LLC et al. v. Genentech, Inc. et al.
Genentech, Inc. v. Immunex Rhode Island Corp.
Genentech, Inc. v. Samsung Bioepis Co., Ltd.
Eli Lilly and Company v. Genentech, Inc.
Standard Essential Patent (SEP) & FRAND Intelligence
5G SEP β’ ETSI Declared High-Probability SEP ActionEssential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation
Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)
Permanent Injunction RestrictedAsserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.